Changes in choroidal thickness after ranibizumab and aflibercept Therapy for treatment ‐naïve wet age‐related macular degeneration

ConclusionsSubfoveal choroidal thickness was decreased after ranibizumab and aflibercept therapy. The mean changes in subfoveal choroidal thickenss was greater in aflibercept injected group at 1 month, but there was no significant difference between two therapy at 2, 3, and 6 months after initial injection.

Source: Acta Ophthalmologica - September 13, 2016 Category: Opthalmology Authors: H.G. Kang, J.S. Kim, J.H. Lee, Y.I. Kim, S.H. Lee Tags: Abstracts from the 2016 European Association for Vision and Eye Research Conference Source Type: research